3/A//SEC Filing
Sun Pharma (Netherlands) B.V. 3/A
Accession 0000925421-17-000354
CIK 0001711279other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 4:55 PM ET
Size
4.9 KB
Accession
0000925421-17-000354
Insider Transaction Report
Form 3/AAmended
Sun Pharma (Netherlands) B.V.
10% Owner
Holdings
Series A Convertible Preferred Stock
→ Common Stock (914,107 underlying)
Footnotes (2)
- [F1]The Series A convertible preferred stock will automatically convert on a one-to-one basis into 914,107 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering.
- [F2]These shares were incorrectly included in the Non-Derivative Securities table in the reporting person's original Form 3, filed September 19, 2017.
Documents
Issuer
Krystal Biotech, Inc.
CIK 0001711279
Entity typeother
IncorporatedNetherlands
Related Parties
1- filerCIK 0001717322
Filing Metadata
- Form type
- 3/A
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 4:55 PM ET
- Size
- 4.9 KB